Idenix Pharmaceuticals (IDIX)

[rwwine]

Price / Share after HCV partnership announcement
...expected later this year

Predictions?

IMHO, all depends on if the deal is for just IDX 184 or both IDX 184 and IDX 320 as you hinted in your question……”HCV partnership announcement”. I think those analysts that are covering IDIX have based for the most part on a partnership for just IDX 184. This as we know is what JP Sommadossi has to some degree has indicated a deal will be agreed to by the end of the calendar year. That being said I am thinking in the $7-$9 range....consistent with many others from all that I have read. If you were to include IDX 320 into the partnership deal and Big Pharma rewards IDIX accordingly.....then I would suggestion $12-$15 as a possible range. Perhaps this is all wishful thinking on my part…..but what IDIX offers is substantial for addressing HCV.

Comments? TIA